That is very important, since the method a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and work. To put it simply, we have to understand how these proteins fold if we desire a drug to work. Historically, this has been a trial-and-error procedure (black sea). However now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much simpler to develop drugs that do what they're designed to do. This was a breakthrough almost no one discovered. But it's going to have profound ramifications for curing disease. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be lots of financial investment opportunities in this space, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (white house). That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be shocked if it pulled back maybe considerably before going greater - tech stocks. I've been covering bitcoin for a long time now. Among the first research reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were mostly informing readers. But that's not the big concern anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche business. Mass, Mutual is a relied on 170-year-old organization. So consider that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. jeff brown biotech stock pick for 2020. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are so many fantastic private companies on the edge of striking the public markets And I have actually been dealing with a brand-new way for you to invest even prior to these companies go public.
This chance has been constructing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the details. Go right here to schedule your area free of charge.
Emma Walsh here, managing editor of the Diary. Regular Diary readers know that tech isn't our usual beat (jeff brown biotech picks). And when it comes to tech investing, we leave it to the professionals. The good news is, we have numerous such specialists in our Rolodex. Our colleague Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing experts we understand (jeff brown tech stock 2021). In fact, he had numerous triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the huge picture and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and a lot more. These patterns are experiencing exponential development and producing incredible chances for investors. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. jeff brown 1 biotech company. However in spite of what lots of readers may believe, this is a pattern that's simply beginning. Despite the fact that the COVID-19 pandemic disrupted supply chains last year, an excellent 250 million 5G-enabled gadgets were still sold.
And all of this ultimately led to Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (bleeding edge). Losing two months of production and sales really affects the number of 5G devices are sold in the calendar year. When you consider all of that, selling 250 million units is exceptional. More significantly, the delays triggered by the pandemic produced a lots of bottled-up need. And that need is now going to be pushed into 2021. In fact, I predict that more than 500 million 5G devices will be shipped in 2021 - jeff brown investment prediction. Which's not my only 5G forecast When I've discussed 5G in the past, I have actually described its three various phases.
In Phase Two, 5G gadgets go on sale. 5G phones and other items begin to reach customers. And in Phase 3, 5G services start to be offered (united arab emirates). That's when we begin to see applications running on 5G networks. Think about things like massive multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Stage Three by this summertime. This starts something of a virtuous cycle: The majority of people do not actually appreciate the technology. But they will care if there are exciting applications that can just be accessed with a 5G phone.
That causes more 5G apps being developed. In truth, 5G is going to open up a suite of incredible applications: self-driving cars and trucks, the Internet of Things, robotic surgery, and more. All of these technologies need 5G. The investment opportunities going forward will be enormous. Stepping far from 5G, the next essential technology I foresee in 2021 is CRISPR hereditary modifying. CRISPR stands for "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it is among the most interesting developments in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software application.
The program can crash or not function correctly. CRISPR utilizes a comparable concept but with our hereditary code. "Typos" in our genome can lead to illness. CRISPR can remedy these "typos." For many years, CRISPR was primarily a niche innovation that wasn't well comprehended. And during that time, there were really only 3 business running in this area. But things are altering. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're dealing with illness and seeing that this innovation just works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and delivering unbelievable returns. This entire industry is successfully a greenfield chance.
There's space for numerous companies to exist in this space. jeff brown top stock pick 2021. And there will be more. That's my forecast for CRISPR in 2021. I predict that 2 or 3 more hereditary modifying business will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things taking place at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its latest Alpha, Fold software can precisely forecast the folding of a protein based solely on its amino acid series with 92. 4% accuracy. That's important since the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been an experimental process. However now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much simpler to create drugs that do what they're developed to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however several drug treatments produced utilizing this innovation. This was among those advancements that almost nobody observed. But it's going to have profound implications for treating disease. And, of course, there will be a lot of investment chances in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it drew back perhaps considerably before going higher. I've been covering bitcoin for a very long time now. Among the very first research reports I ever released was on bitcoin - jeff brown top biotech 2020. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anyone who followed my suggestion. But at the time of that preliminary suggestion, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
But nobody is asking that concern anymore. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. jeff brown biotech pick. Mass, Mutual is a 150-year-old institution. So think of that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and declares the information depends on date as of February 2021, but we might not individually verify this claim. Provided Jeff Brown's past, he likely has a significant net worth, but we can't hammer down a precise figure at this minute. Brown is best understood for his sage-like ability to pick winning innovation stocks. He spent more than 25 years researching technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an excellent perspective on the marketplace. He's constantly on the hunt for brand-new chances, and he shares much of his finest picks in the Future Report.
That's high praise, but it's not absurdly reasoned. Brown has an outstanding reputation as a stock-picker, and he successfully predicted a few of the greatest economic events of the past twenty years. Although he does not appear to release his choices to the public, the service's success is a direct sign of Brown's stock-picking prowess. Nobody on Wall Street gets it ideal every time, but Jeff Brown's accurate predictions have made him legions of dedicated followers. That states a lot about his ability. The Future Report is published by Brownstone Research, a popular monetary research study publisher. Brownstone Research offers numerous research services with a variety of specializations - jeff brown.
The business is also affiliated with Bonner & Partners, another well-respected research publisher - artificial intelligence. On its website, Brownstone says its objective is to provide retail financiers with professional-grade research: "For too long, the finest financial investment research study has not been readily available to private financiers. It has been generally scheduled for investment banks, hedge funds, private equity, and high-net-worth clients. biotech stocks jeff brown. The objective of Brownstone Research study is to make that type of proprietary research available to any financiers aiming to get an edge in the marketplaces. The goal is easy to deliver unique and profitable investment research found nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research, and he likewise serves as the firm's Chief Financial investment Expert.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to use its clients. After decades of steady success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout many of America. If you know even a little bit about the marketplace, you understand that he has a track record as a King Midas of sorts. the legacy report predictions. Whatever he touches turns to gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big task.
In truth, Brown thinks S.A.V. jeff bezos. might be "the biggest pattern of the 2020s, and he's not alone. Check out these quotes from other popular S.A.V. bulls: Elon's next huge act will be weding two advanced innovations: artificial intelligence and electrical automobiles. Musk hopes the mix will help him develop the very first fully-autonomous, self-driving automobiles ever. It's absolutely nothing short of the automotive market's Holy Grail. As you know, electrical automobiles and self-driving automobile stocks have actually been huge this year, but the Wall Street maker has actually approved buzz without much concrete outcome. Regardless of a drastic increase in competitors over the past few years, Brown still believes Musk has the very best chance of putting everything together.
tech might be the magic string that ties it all together. S.A.V. stands for Shared Autonomous Lorry, and it might be the future of transport. Essentially, this technology would enable you to rent out your vehicle as an autonomous, self-driving taxi when you're not using it. You simply get out of the vehicle and press a button on an app that informs the cars and truck to "sign up with the fleet." Next thing you know, you're relaxing on your sofa while your car shuttles ride-sharers around town. Most importantly, you get to keep a substantial chunk of the earnings. It sounds outrageous, however it could be closed than you believe.